[Skip to Navigation]
Views 849
Citations 0
Comment & Response
August 19, 2020

Does Degarelix Hold Potential for the Treatment of Pedophilic Disorder?—Reply

Author Affiliations
  • 1Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
  • 2Institute of Neuroscience and Physiology, Gothenburg University, Gothenburg, Sweden
  • 3Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
JAMA Psychiatry. 2020;77(10):1085. doi:10.1001/jamapsychiatry.2020.2597

In Reply We welcome the interest in our Original Investigation1 expressed by ElSayed and Gupta. Regarding the question posed in their title, the answer is yes, the results from our clinical trial show that degarelix holds potential to be a tolerable treatment with significant short-term risk-reduction effects in help-seeking patients with pedophilic disorder, including high-risk patients.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words